BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Carroll MJ, Kapur A, Felder M, Patankar MS, Kreeger PK. M2 macrophages induce ovarian cancer cell proliferation via a heparin binding epidermal growth factor/matrix metalloproteinase 9 intercellular feedback loop. Oncotarget 2016;7:86608-20. [PMID: 27888810 DOI: 10.18632/oncotarget.13474] [Cited by in Crossref: 28] [Cited by in F6Publishing: 35] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Carroll MJ, Kaipio K, Hynninen J, Carpen O, Hautaniemi S, Page D, Kreeger PK. A Subset of Secreted Proteins in Ascites Can Predict Platinum-Free Interval in Ovarian Cancer. Cancers 2022;14:4291. [DOI: 10.3390/cancers14174291] [Reference Citation Analysis]
2 Reis-Sobreiro M, Teixeira da Mota A, Jardim C, Serre K. Bringing Macrophages to the Frontline against Cancer: Current Immunotherapies Targeting Macrophages. Cells 2021;10:2364. [PMID: 34572013 DOI: 10.3390/cells10092364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Xiong J, He X, Xu Y, Zhang W, Fu F. MiR-200b is upregulated in plasma-derived exosomes and functions as an oncogene by promoting macrophage M2 polarization in ovarian cancer. J Ovarian Res 2021;14:74. [PMID: 34078414 DOI: 10.1186/s13048-021-00826-9] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
4 Wang L, Gao Y, Tong D, Wang X, Guo C, Guo B, Yang Y, Zhao L, Zhang J, Yang J, Qin Y, Liu L, Huang C. MeCP2 drives hepatocellular carcinoma progression via enforcing HOXD3 promoter methylation and expression through the HB-EGF/EGFR pathway. Mol Oncol 2021. [PMID: 34028973 DOI: 10.1002/1878-0261.13019] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
5 Li X, Liu Y, Zheng S, Zhang T, Wu J, Sun Y, Zhang J, Liu G. Role of exosomes in the immune microenvironment of ovarian cancer. Oncol Lett 2021;21:377. [PMID: 33777201 DOI: 10.3892/ol.2021.12638] [Cited by in Crossref: 2] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
6 Ghoneum A, Almousa S, Warren B, Abdulfattah AY, Shu J, Abouelfadl H, Gonzalez D, Livingston C, Said N. Exploring the clinical value of tumor microenvironment in platinum-resistant ovarian cancer. Semin Cancer Biol 2021:S1044-579X(21)00003-1. [PMID: 33476723 DOI: 10.1016/j.semcancer.2020.12.024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
7 Cadena I, Chen A, Arvidson A, Fogg KC. Biomaterial strategies to replicate gynecological tissue. Biomater Sci 2021;9:1117-34. [DOI: 10.1039/d0bm01240h] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
8 Wang X, Gao S, Song L, Liu M, Sun Z, Liu J. Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axis. Mol Immunol 2021;130:113-21. [PMID: 33308900 DOI: 10.1016/j.molimm.2020.11.014] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
9 Zhang Z, Huang L, Brayboy L. Macrophages: an indispensable piece of ovarian health. Biol Reprod 2021;104:527-38. [PMID: 33274732 DOI: 10.1093/biolre/ioaa219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
10 Fogg KC, Miller AE, Li Y, Flanigan W, Walker A, O'Shea A, Kendziorski C, Kreeger PK. Ovarian cancer cells direct monocyte differentiation through a non-canonical pathway. BMC Cancer 2020;20:1008. [PMID: 33069212 DOI: 10.1186/s12885-020-07513-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Dong ZR, Sun D, Yang YF, Zhou W, Wu R, Wang XW, Shi K, Yan YC, Yan LJ, Yao CY, Chen ZQ, Zhi XT, Li T. TMPRSS4 Drives Angiogenesis in Hepatocellular Carcinoma by Promoting HB-EGF Expression and Proteolytic Cleavage. Hepatology 2020;72:923-39. [PMID: 31867749 DOI: 10.1002/hep.31076] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 7.0] [Reference Citation Analysis]
12 Baek SH, Lee HW, Gangadaran P, Oh JM, Zhu L, Rajendran RL, Lee J, Ahn BC. Role of M2-like macrophages in the progression of ovarian cancer. Exp Cell Res 2020;395:112211. [PMID: 32755554 DOI: 10.1016/j.yexcr.2020.112211] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
13 Puthenveetil A, Dubey S. Metabolic reprograming of tumor-associated macrophages. Ann Transl Med 2020;8:1030. [PMID: 32953830 DOI: 10.21037/atm-20-2037] [Cited by in Crossref: 12] [Cited by in F6Publishing: 22] [Article Influence: 6.0] [Reference Citation Analysis]
14 Mcmullen M, Madariaga A, Lheureux S. New approaches for targeting platinum-resistant ovarian cancer. Seminars in Cancer Biology 2020. [DOI: 10.1016/j.semcancer.2020.08.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
15 Wu A, Zhang S, Liu J, Huang Y, Deng W, Shu G, Yin G. Integrated Analysis of Prognostic and Immune Associated Integrin Family in Ovarian Cancer. Front Genet 2020;11:705. [PMID: 32765584 DOI: 10.3389/fgene.2020.00705] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
16 Fogg KC, Renner CM, Christian H, Walker A, Marty-Santos L, Khan A, Olson WR, Parent C, O'Shea A, Wellik DM, Weisman PS, Kreeger PK. Ovarian Cells Have Increased Proliferation in Response to Heparin-Binding Epidermal Growth Factor as Collagen Density Increases. Tissue Eng Part A 2020;26:747-58. [PMID: 32598229 DOI: 10.1089/ten.tea.2020.0001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
17 Fu E, Liu T, Yu S, Chen X, Song L, Lou H, Ma F, Zhang S, Hussain S, Guo J, Sun J, Yu P, Mao X, Wei L. M2 macrophages reduce the radiosensitivity of head and neck cancer by releasing HB‑EGF. Oncol Rep 2020;44:698-710. [PMID: 32627036 DOI: 10.3892/or.2020.7628] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
18 Baci D, Bosi A, Gallazzi M, Rizzi M, Noonan DM, Poggi A, Bruno A, Mortara L. The Ovarian Cancer Tumor Immune Microenvironment (TIME) as Target for Therapy: A Focus on Innate Immunity Cells as Therapeutic Effectors. Int J Mol Sci 2020;21:E3125. [PMID: 32354198 DOI: 10.3390/ijms21093125] [Cited by in Crossref: 16] [Cited by in F6Publishing: 36] [Article Influence: 8.0] [Reference Citation Analysis]
19 Luo P, Yan H, Chen X, Zhang Y, Zhao Z, Cao J, Zhu Y, Du J, Xu Z, Zhang X, Zeng S, Yang B, Ma S, He Q. s-HBEGF/SIRT1 circuit-dictated crosstalk between vascular endothelial cells and keratinocytes mediates sorafenib-induced hand-foot skin reaction that can be reversed by nicotinamide. Cell Res 2020;30:779-93. [PMID: 32296111 DOI: 10.1038/s41422-020-0309-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
20 Fogg KC, Olson WR, Miller JN, Khan A, Renner C, Hale I, Weisman PS, Kreeger PK. Alternatively activated macrophage-derived secretome stimulates ovarian cancer spheroid spreading through a JAK2/STAT3 pathway. Cancer Lett 2019;458:92-101. [PMID: 31129149 DOI: 10.1016/j.canlet.2019.05.029] [Cited by in Crossref: 11] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
21 Zhang J, Li H, Wu Q, Chen Y, Deng Y, Yang Z, Zhang L, Liu B. Tumoral NOX4 recruits M2 tumor-associated macrophages via ROS/PI3K signaling-dependent various cytokine production to promote NSCLC growth. Redox Biol 2019;22:101116. [PMID: 30769285 DOI: 10.1016/j.redox.2019.101116] [Cited by in Crossref: 21] [Cited by in F6Publishing: 42] [Article Influence: 7.0] [Reference Citation Analysis]
22 Motohara T, Masuda K, Morotti M, Zheng Y, El-Sahhar S, Chong KY, Wietek N, Alsaadi A, Karaminejadranjbar M, Hu Z, Artibani M, Gonzalez LS, Katabuchi H, Saya H, Ahmed AA. An evolving story of the metastatic voyage of ovarian cancer cells: cellular and molecular orchestration of the adipose-rich metastatic microenvironment. Oncogene 2019;38:2885-98. [PMID: 30568223 DOI: 10.1038/s41388-018-0637-x] [Cited by in Crossref: 54] [Cited by in F6Publishing: 80] [Article Influence: 13.5] [Reference Citation Analysis]
23 Gupta V, Yull F, Khabele D. Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy. Cancers (Basel) 2018;10:E366. [PMID: 30274280 DOI: 10.3390/cancers10100366] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
24 Gupta V, Yull F, Khabele D. Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy. Cancers (Basel) 2018;10:E366. [PMID: 30274280 DOI: 10.3390/cancers10100366] [Cited by in Crossref: 37] [Cited by in F6Publishing: 43] [Article Influence: 9.3] [Reference Citation Analysis]
25 Gupta V, Yull F, Khabele D. Bipolar Tumor-Associated Macrophages in Ovarian Cancer as Targets for Therapy. Cancers (Basel) 2018;10:E366. [PMID: 30274280 DOI: 10.3390/cancers10100366] [Reference Citation Analysis]
26 Drakes ML, Stiff PJ. Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment. Cancers (Basel) 2018;10:E302. [PMID: 30200478 DOI: 10.3390/cancers10090302] [Cited by in Crossref: 42] [Cited by in F6Publishing: 47] [Article Influence: 10.5] [Reference Citation Analysis]
27 Drakes ML, Stiff PJ. Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment. Cancers (Basel) 2018;10:E302. [PMID: 30200478 DOI: 10.3390/cancers10090302] [Reference Citation Analysis]
28 Drakes ML, Stiff PJ. Regulation of Ovarian Cancer Prognosis by Immune Cells in the Tumor Microenvironment. Cancers (Basel) 2018;10:E302. [PMID: 30200478 DOI: 10.3390/cancers10090302] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
29 Yesil-celiktas O, Hassan S, Miri AK, Maharjan S, Al-kharboosh R, Quiñones-hinojosa A, Zhang YS. Mimicking Human Pathophysiology in Organ-on-Chip Devices. Adv Biosys 2018;2:1800109. [DOI: 10.1002/adbi.201800109] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
30 Bishehsari F, Zhang L, Barlass U, Preite NZ, Turturro S, Najor MS, Shetuni BB, Zayas JP, Mahdavinia M, Abukhdeir AM, Keshavarzian A. KRAS mutation and epithelial-macrophage interplay in pancreatic neoplastic transformation. Int J Cancer 2018;143:1994-2007. [PMID: 29756386 DOI: 10.1002/ijc.31592] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 2.8] [Reference Citation Analysis]
31 Rea K, Roggiani F, De Cecco L, Raspagliesi F, Carcangiu ML, Nair-Menon J, Bagnoli M, Bortolomai I, Mezzanzanica D, Canevari S, Kourtidis A, Anastasiadis PZ, Tomassetti A. Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth. J Exp Clin Cancer Res 2018;37:146. [PMID: 29996940 DOI: 10.1186/s13046-018-0796-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
32 Carroll MJ, Fogg KC, Patel HA, Krause HB, Mancha AS, Patankar MS, Weisman PS, Barroilhet L, Kreeger PK. Alternatively-Activated Macrophages Upregulate Mesothelial Expression of P-Selectin to Enhance Adhesion of Ovarian Cancer Cells. Cancer Res 2018;78:3560-73. [PMID: 29739756 DOI: 10.1158/0008-5472.CAN-17-3341] [Cited by in Crossref: 11] [Cited by in F6Publishing: 22] [Article Influence: 2.8] [Reference Citation Analysis]
33 Zhang B, Chen F, Xu Q, Han L, Xu J, Gao L, Sun X, Li Y, Li Y, Qian M, Sun Y. Revisiting ovarian cancer microenvironment: a friend or a foe? Protein Cell 2018;9:674-92. [PMID: 28929459 DOI: 10.1007/s13238-017-0466-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 21] [Article Influence: 2.6] [Reference Citation Analysis]
34 Peng Z, Jia J, Gong W, Gao X, Ma P, Jin Z, Fan Y, Li Y, Zhang X. The association of matrix metalloproteinase-9 promoter polymorphisms with gastric cancer risk: a meta-analysis. Oncotarget 2017;8:99024-32. [PMID: 29228747 DOI: 10.18632/oncotarget.20931] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
35 Yang H, Chen Y, Gao C. Interleukin-13 reduces cardiac injury and prevents heart dysfunction in viral myocarditis via enhanced M2 macrophage polarization. Oncotarget 2017;8:99495-503. [PMID: 29245918 DOI: 10.18632/oncotarget.20111] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]